# US 2021/0333278 A1 · Viral respiratory infection detection device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0333278 A1
- Document ID: US20210333278A1
- Status: Published application
- Kind: A1
- Application number: 17/242,887
- Filed: 2021-04-28
- Published: 2021-10-28
- Earliest claimed: 2020-04-28
- Assignees: Core Diagnostics Corporation
- Applicants: Core Diagnostics Corporation
- Inventors: Wilma MANGAN
- Web page: https://patentgrep.com/patent/US20210333278A1

## CPC

- G01N 33/56983: {Viruses}
- B01L 3/5023: {with a sample being transported to, and subsequently stored in an absorbent for analysis}
- G01N 33/54388: {based on lateral flow}
- G01N 33/54389: {with bidirectional or multidirectional lateral flow, e.g. wherein the sample flows from a single, common sample application point into multiple strips, lanes or zones}
- B01L 2300/0681: Filter
- B01L 2300/0825: Test strips
- B01L 2300/0864: comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
- B01L 2300/161: Control and use of surface tension forces, e.g. hydrophobic, hydrophilic
- B01L 2400/0406: capillary forces
- G01N 2333/165: Coronaviridae, e.g. avian infectious bronchitis virus
- G01N 2333/705: Assays involving receptors, cell surface antigens or cell surface determinants
- G01N 2469/10: Detection of antigens from microorganism in sample from host
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE

## Abstract

The present disclosure may provide a system and method for using a viral respiratory infection detection device, a method comprising: obtaining a biological sample from a subject; preparing the biological sample for testing; placing at least a portion of the prepared biological sample into a sample port of a viral respiratory infection detection device thereby contacting a sample pad with the prepared biological sample thus initiating a first test strip and a second test strip, wherein the first testing strip is formed to detect the binding of a respiratory virus to a recombinant human receptor protein, wherein the second testing strip is formed to detect the binding of a specific respiratory virus to a specific recombinant spike glycoprotein; and analyzing the results of the first test strip and the second test strip.

## Claims

### Claim 1

A method for detecting a viral infection, the method comprising:
obtaining a biological sample from a subject;
placing at least a portion of the biological sample into a sample port of a viral infection detection device to contact a sample pad with the biological sample and initiate a detection test on a first test strip and also a second test strip, wherein the first test strip detects the binding of a respiratory virus to a recombinant human receptor protein, wherein the second test strip detects the binding of a specific virus to a specific recombinant spike glycoprotein; and
analyzing the results of the detection test initiated on the first test strip and the second test strip.

### Claim 2 (depends on 1)

The method of claim 1, wherein the viral infection detection device comprises a body having the sample pad disposed therein; wherein the body comprises a material selected from the group consisting of polyester, polyethylene terephthalate glycol-modified, polyethylene terephthalate, polyethylene terephthalate, polybutylene terephthalate, polytrimethylene terephthalate, polyethylene naphthalate, polycarbonate, polyvinyl chloride, polystyrene, styrene-acrylonitrile resin, acrylonitrile-butadiene-styrene, and any combinations thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the first test strip and the second test strip are formed on solid support configured to transport a fluid through an interconnected series of capillary beds.

### Claim 4 (depends on 3)

The method of claim 3, wherein the solid support comprises a hydrophobic plastic modified to render a surface of the solid support to be hydrophilic.

### Claim 5 (depends on 4)

The method of claim 4, wherein the hydrophobic solid support is modified by a plasma etching and corona treatment.

### Claim 6 (depends on 3)

The method of claim 3, wherein the solid support comprises a material selected from the group consisting of porous paper, microstructured polymers, sintered polymers, and any combination thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein at least one of the detection tests is a qualitative lateral flow immunoassay.

### Claim 8 (depends on 7)

The method of claim 7, wherein the qualitative lateral flow immunoassay is a qualitative lateral flow immunoassay selected from the group consisting of a competitive homogeneous immunoassay, a competitive heterogeneous immunoassay, a one-site noncompetitive immunoassay, a two-site noncompetitive immunoassay, and any combinations thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the sample pad comprises a plurality of stacked membranes used to trap red cells and allow plasma or serum to flow to the specific test capturing biomarker.

### Claim 10 (depends on 1)

The method of claim 1, wherein the recombinant human receptor protein comprises a recombinant angiotensin-converting enzyme 2 receptor.

### Claim 11 (depends on 1)

The method of claim 1, wherein the recombinant spike glycoprotein comprises a spike glycoprotein trimer nucleoprotein of a coronavirus.

### Claim 12 (depends on 1)

The method of claim 1, wherein the analyzing the results of the detection test comprises viewing a marker on at least one of the first test strip or second test strip.

### Claim 13 (depends on 1)

The method of claim 1, wherein the marker is visible for viewing to a human eye.

### Claim 14

A viral infection detection device comprising:
a sample pad comprising a first test strip and also a second test strip, wherein the first test strip detects the binding of a respiratory virus to a recombinant human receptor protein, and wherein the second test strip detects the binding of a specific virus to a specific recombinant spike glycoprotein; and
a body, wherein the sample is disposed within the body.

### Claim 15 (depends on 14)

The viral infection detection device of claim 14, wherein the body comprises a material selected from the group consisting of polyester, polyethylene terephthalate glycol-modified, polyethylene terephthalate, polyethylene terephthalate, polybutylene terephthalate, polytrimethylene terephthalate, polyethylene naphthalate, polycarbonate, polyvinyl chloride, polystyrene, styrene-acrylonitrile resin, acrylonitrile-butadiene-styrene, and any combinations thereof.

### Claim 16 (depends on 14)

The viral infection detection device of claim 14, wherein the first test strip and the second test strip are formed on solid support configured to transport a fluid through an interconnected series of capillary beds.

### Claim 17 (depends on 16)

The viral infection detection device of claim 16, wherein the solid support comprises a hydrophobic plastic modified to render a surface of the solid support to be hydrophilic.

### Claim 18 (depends on 14)

The viral infection detection device of claim 14, wherein the sample pad comprises a plurality of stacked membranes used to trap red cells and allow plasma or serum to flow to the specific test capturing biomarker.

### Claim 19 (depends on 14)

The viral infection detection device of claim 14, wherein the recombinant human receptor protein comprises a recombinant angiotensin-converting enzyme 2 receptor.

### Claim 20 (depends on 14)

The viral infection detection device of claim 14, wherein the recombinant spike glycoprotein comprises a spike glycoprotein trimer nucleoprotein of a coronavirus.
